Everlab Raises US$10 Million to Scale AI-Driven Preventive Health Platform Globally

Everlab, the AI-powered health platform reimagining preventive care, announced a US$10 million (AU$15 million) seed round led by global growth equity fir...

July 22, 2025 | Tuesday | News
Gelteq Partners with IDT Australia to Establish Dedicated Manufacturing Facility for Global Gel-Based Therapeutics

Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white ...

July 21, 2025 | Monday | News
Johnson & Johnson’s TAR-200 Receives FDA Priority Review for BCG-Unresponsive Bladder Cancer

New Drug Application supported by results from the Phase 2b SunRISe-1 study Johnson & Johnson announced that the U.S. Food and Drug Administration (...

July 18, 2025 | Friday | News
Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield to Expand U.S. Drug Production Capabilities

Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additiona...

July 17, 2025 | Thursday | News
Qosina Expands Distribution Partnership with Saint-Gobain, Adding 38 New Tubing SKUs to Support Bioprocessing Needs

Qosina, a leading global supplier of OEM single-use components to the medical and bioprocess industries, is pleased to announce the expansion of its part...

July 17, 2025 | Thursday | News
Oragenics Partners with Sterling Pharma for U.S.-Based GMP Manufacturing of Intranasal Concussion Drug ONP-002

Oragenics, Inc., a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has entered into a manufactu...

July 17, 2025 | Thursday | News
Addgene and Promega Launch Plasmid Collection to Accelerate Drug Discovery Research

Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed, and reproducibility,  announced a strategic ...

July 16, 2025 | Wednesday | News
Ultragenyx Receives Complete Response Letter from FDA for UX111 Gene Therapy for Sanfilippo Syndrome Type A

Ultragenyx Pharmaceutical Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its Biologics L...

July 14, 2025 | Monday | News
Trethera’s TRE-515 Receives FDA Fast Track Designation for Advanced Prostate Cancer Treatment

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune d...

July 11, 2025 | Friday | News
Zhimeng Biopharma Receives CDE Approval to Advance CB03-154 into Phase 2/3 Trials for ALS in China

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and...

July 10, 2025 | Thursday | News
Amarna Therapeutics and NorthX Biologics Advance Gene Therapy Manufacturing for Type 1 Diabetes

Amarna Therapeutics, (“Amarna” or “the Company”), a privately held biotechnology company pioneering transformative gene therapies...

July 09, 2025 | Wednesday | News
Certara Expands Partnership with Merck to Advance Metadata and Data Standards Management

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced a new collaboration with Merck, known as MSD outside of...

July 09, 2025 | Wednesday | News
Conduit Pharmaceuticals Expands IP Portfolio with Four New Patent Filings for AZD1656 and AZD5658

Conduit Pharmaceuticals Inc.  announces the filing of four new patent applications relating to its key assets AZD1656 and AZD5658, including the Com...

July 08, 2025 | Tuesday | News
Synfini Secures $8.9M to Accelerate AI-Driven Chemistry Automation, Bringing Total Funding to $53M

Synfini, Inc., a trailblazer in AI-driven chemistry automation, today announced a $8.9 million expansion of its round, led by JSL Health Capital and supp...

July 08, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close